Pregnancy
The safety of Kaletra in pregnant women has not been established, but animal studies have shown some toxicity. Lopinavir also crosses the placenta, reaching effective anti-HIV levels in the foetus[1]. Kaletra should not be used in pregnancy unless clearly necessary
latest aidsmap news
- Traditional healers could play key role in ART rollout
- HIV testing for mothers and children must expand, UN report shows
- London hospital to test new HIV vaccine candidate
- Counselling sessions can reduce reported risky sex by HIV-positive gay men
- HIV diagnoses in European MSM have almost doubled since 2000, UK tops the list
- Older HIV-positive gay men as likely to have risky sex as younger gay men with HIV
- Mbeki's opposition to ARVs cost 330,000 lives, shows study
- Universal testing and treatment could reduce new HIV infections in southern Africa by 95% in 10 years
- Record number of people accessing HIV care in the UK
- Treatment during primary HIV infection has limited benefit